Chemotherapy in Treating Patients With Early-Stage Bladder Cancer
Completed
National Cancer Institute (NCI)
Phase 2
1998-07-01
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so
they stop growing or die.
PURPOSE: Phase II trial to study the effectiveness of chemotherapy in treating patients with
early-stage bladder cancer that has not responded to BCG therapy.
Chemotherapy in Treating Patients With Early-Stage Bladder Cancer
Completed
Eastern Cooperative Oncology Group
Phase 2
1998-07-01
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so
they stop growing or die.
PURPOSE: Phase II trial to study the effectiveness of chemotherapy in treating patients with
early-stage bladder cancer that has not responded to BCG therapy.
Surgery With or Without Chemotherapy in Treating Patients With Newly Diagnosed or Recurrent Bladder Cancer
Unknown status
Anthra Pharmaceuticals
Phase 3
1996-12-01
RATIONALE: Transurethral resection is a less invasive type of surgery for bladder cancer and
may have fewer side effects and improve recovery. Drugs used in chemotherapy use different
ways to stop tumor cells from dividing so they stop growing or die. It is not yet known
whether transurethral resection plus AD 32 is more effective than transurethral resection
alone for bladder cancer.
PURPOSE: Randomized phase III trial to compare the effectiveness of transurethral resection
surgery followed by AD 32 with that of transurethral resection alone in treating patients who
have newly diagnosed or recurrent bladder cancer.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
